Search results
The Rock 'The Smashing Machine' movie: What to know about Dwayne Johnson film about former MMA star...
Sporting News· 2 days agoGet ready to see Dwayne "The Rock" Johnson like never before. Johnson has left his mark across a...
Dwayne Johnson Transforms In First Pic From A24's The Smashing Machine
Bleeding Cool· 2 days agoA24 has released the first photo of Dwayne Johnson as MMA fighter Mark Kerr in the new film The...
Dwayne Johnson Is Unrecognizable In First Look Image As Mark Kerr In A24’s ‘The Smashing Machine’
Blavity via Yahoo News· 2 days agoDwayne Johnson has turned into Mark Kerr in the new first-look image from The Smashing Machine,...
Dwayne ‘The Rock’ Johnson looks totally unrecognisable in first-look appearance for new UFC movie
GiveMeSport· 1 day agoDwayne Johnson, aka The Rock, is taking a break from over-the-top action movies to play his heaviest...
A24 unveils first look at Dwayne Johnson The Smashing Machine
ClutchPoints· 1 day agoA24 just released the first look at Dwayne Johnson as Mark Kerr in Benny Safdie's The Smashing...
Dwayne Johnson Transforms Into Legendary MMA Fighter Mark Kerr For A24’s ‘The Smashing Machine’
Deadline via Yahoo News· 2 days agoDwayne Johnson is almost unrecognizable as MMA legend Mark Kerr in a first look at A24’s The...
The Smashing Machine: Dwayne "The Rock" Johnson is Unrecognizable In A24 Biopic's First Look
Comic Book· 2 days agoThe Smashing Machine landed Uncut Gems director Benny Safdie to helm the project and also has had...
Third Party Withdraws Appeal Related to Cantargia Patent
Digital Journal· 7 days ago(ticker: CANTA). More information about Cantargia is available at www.cantargia.com . About nadunolimab (CAN04) The antibody nadunolimab binds strongly to its target IL1RAP and functions by ...
Q2 2024 EPS Estimates for iTeos Therapeutics, Inc. Lifted by HC Wainwright (NASDAQ:ITOS)
ETF DAILY NEWS· 7 days agoiTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Stock analysts at HC Wainwright raised their Q2 2024 earnings estimates for shares of iTeos Therapeutics in a research note issued to investors ...